Journal profile · Hematology
Seminars in Hematology
ISSN 0037-1963 · eISSN 1532-8686 · W.B. Saunders Ltd · UNITED STATES · Quarterly · Founded 1964
Seminars in Hematology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.26; hybrid open access; APC about USD 4,070; median 55 days to acceptance (71 articles, last 24 months); community-reported acceptance: moderate; 61 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Seminars in Hematology is published by W.B. Saunders Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research and Platelet Disorders and Treatments, together about 22.6% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Seminars in Hematology is a review journal dedicated to subjects of current importance in clinical hematology, including related areas of oncology, hematopathology, and blood banking.Every issue is edited by a guest editor or editors, an internationally acknowledged expert(s) in the field, and contains authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively multi-faceted overview of a selected area.Seminars in Hematology is devoted to making the important and current work readily accessible, comprehensible, and valuable to the practicing physician, young investigator, clinical practitioners, and internists/paediatricians with strong interests in blood diseases.
From the journal's Aims & Scope
Research area (LetPub): Hematology
Editor-in-chief Adrian WiestnerPublisher website
Editorial board by country: none in mainland China; most named United States 11, Australia 3 (14 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Myeloid Leukemia ResearchMedicine8.2%
- Chronic Lymphocytic Leukemia ResearchMedicine7.6%
- Platelet Disorders and TreatmentsMedicine6.9%
- Lymphoma Diagnosis and TreatmentMedicine6.7%
- Chronic Myeloid Leukemia TreatmentsMedicine6%
- Hematopoietic Stem Cell TransplantationMedicine5.5%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance5.4%
- Hemoglobinopathies and Related DisordersMedicine5.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.26LetPub ·
- Impact factor (publisher)
- 4.3Publisher website ·
- CiteScore 2026-06
- 7.5LetPub ·
- CiteScore (publisher)
- 7.5Publisher website ·
- SJR 2026-06
- 1.34LetPub ·
- SNIP 2026-06
- 1.24LetPub ·
- h-index
- 88LetPub ·
- h-index
- 107OpenAlex ·
- i10-index
- 1,103OpenAlex ·
- 2-year mean citedness
- 3.93OpenAlex ·
- Self-citation rate
- 2.3%LetPub ·
- Share of gold OA articles
- 24.19%LetPub ·
Volume
- Articles per year
- 31LetPub ·
Articles by year OpenAlex count · 2,198 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 24 | 7 | 2 |
| 2025 | 61 | 20 | 189 |
| 2024 | 68 | 33 | 411 |
| 2023 | 54 | 23 | 764 |
| 2022 | 37 | 19 | 620 |
| 2021 | 29 | 8 | 633 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
55 daysMedian, submission to acceptance · P25–P75 23 days – 86 days
- Acceptance to online
- median 4 days (70 articles)
- Submission to online
- median 59 days
- Sample
- 71 articles with submission and acceptance dates (95 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 16 daysPublisher website ·
- Submission to acceptance
- 12 daysPublisher website ·
- Acceptance to publication
- 4 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,070 / EUR 3,810 / GBP 3,260 / JPY 504,800 | — | — | |
| Publisher website | USD 4,310 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare10 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted1, with length limits
- reviewThis journal publishes reviews only. These should not exceed 6,000 words excluding references (typically less than 150). They may include up to 6 figures and ta…main text ≤ 6,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
Submission declaration: work not published previously (except preprint, abstract, lecture, thesis, registered report); not under consideration elsewhere; approved by all authors; not published elsewhere without consent. Model summary
By adhering to the authorship requirements stated above, authors meet the International Committee of Medical Journal Editors (ICMJE) criteria [updated version January 2024] on authorship.
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Data availability
Data statement encouraged at submission; appears with published article on ScienceDirect. Model summary
To foster transparency, you are encouraged to state the availability of any data at submission.
Source ↗Publisher website ·- Publication ethics
Authors must follow Elsevier's Publishing Ethics Policy. Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Submission by invitation; each issue edited by guest editor(s) with authoritative invited reviews. Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process; submissions initially assessed by editors, then reviewed by a minimum of one reviewer; decision made by editors. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of one reviewer for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Rea…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed per Elsevier's article sharing policy; does not count as prior publication. Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- W.B. Saunders Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1964
- ISSN
- 0037-1963
- Electronic ISSN
- 1532-8686
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Seminars in Hematology
What CAS zone is Seminars in Hematology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Seminars in Hematology is in Zone 2 of Medicine, and in Zone 2 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Seminars in Hematology?
The latest impact factor listed by LetPub is 4.26; CiteScore 7.5, h-index 107.
How long does peer review take at Seminars in Hematology?
Based on the dates recorded on 71 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 55 days (interquartile range 23–86 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Seminars in Hematology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Seminars in Hematology based?
Of the 14 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (11) and Australia (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Seminars in Hematology?
According to LetPub and DOAJ records, Seminars in Hematology is indexed in SCIE and Scopus.
Is Seminars in Hematology open access, and what is the APC?
Seminars in Hematology is a hybrid journal. For open-access publication: APC about USD 4,070.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .